Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12614000632695
Ethics application status
Approved
Date submitted
28/05/2014
Date registered
13/06/2014
Date last updated
24/07/2018
Type of registration
Retrospectively registered

Titles & IDs
Public title
Optimized carbon dioxide pressure in retroperitoneoscopic adrenalectomy
Scientific title
Comparison of physiological response between different insufflated carbon dioxide pressures in patients undergoing retroperitoneoscopic adrenalectomy for adrenal tumors
Secondary ID [1] 284691 0
Nil
Universal Trial Number (UTN)
U1111-1157-4467
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Adrenal tumors 292045 0
Condition category
Condition code
Surgery 292381 292381 0 0
Surgical techniques
Anaesthesiology 292399 292399 0 0
Anaesthetics
Metabolic and Endocrine 292400 292400 0 0
Other metabolic disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Study Procedures:
All patients will undergo retro-peritoneoscopic adrenalectomy. A opening into the retroperitoneal space will be created below the tip of the 12 th rib. A 12 mm balloon port will be placed into the retroperitoneal space after which carbon dioxide will be administered into the retroperitoneal space. The carbon dioxide will be administered throughout the procedure. The current study proposes to administer a pressure of 25 mmHg in group A and 20 mmHg in Group B.
If the surgeon believes there is impaired visibility or bleeding in group B, the CO2 pressure is increased to 25 mmHg. If the patient experiences CO2 retention, the operation will be halted, and then restarted at the pressured used, in line with current clinical routine.

Routine clinical blood samples (arterial line blood gases) will be taken every thirty minutes according to the clinical routine. The results of these blood samples are recorded for data analysis. Also, clinical data such as blood pressure, central venous pressure, respiratory minute volume, Tidal volume, and End tidal carbon dioxide level will be collected every thirty minutes. Other clinical data such as patient age, gender, tumor size, pathology of tumor, and operative time are also recorded.
Intervention code [1] 289481 0
Treatment: Surgery
Comparator / control treatment
20 mmHg (low pressure) versus 25 mmHg (standard pressure) of insufflated carbon dioxide pressure
Control group
Active

Outcomes
Primary outcome [1] 292241 0
Pressure of carbon dioxide (CO2) by arterial blood gas analysis
Timepoint [1] 292241 0
60 minutes after insufflation
Primary outcome [2] 292260 0
pH in an arterial bloodgas analysis
Timepoint [2] 292260 0
60 minutes
Primary outcome [3] 292261 0
End tidal CO2 (measurement of CO2 by Capnography.)
Timepoint [3] 292261 0
60 minutes
Secondary outcome [1] 308521 0
Pressure of carbon dioxide (CO2) by arterial blood gas analysis
Timepoint [1] 308521 0
30 minutes
Secondary outcome [2] 308581 0
Subjective increase of bleeding defined as surgeon decision to increase pressure.
Timepoint [2] 308581 0
Duration of surgery.
Secondary outcome [3] 308582 0
pH in an arterial bloodgas analysis
Timepoint [3] 308582 0
30 minutes
Secondary outcome [4] 308583 0
End tidal CO2 (measurement of CO2 by Capnography.)
Timepoint [4] 308583 0
30 minutes
Secondary outcome [5] 308584 0
Operative time
Timepoint [5] 308584 0
From start of surgery to end of surgery.
Start defined as time of skin incision
End defined as time of all wounds sutured.

Eligibility
Key inclusion criteria
All adult patients undergoing retroperitoneoscopic adrenalectomy at north shore private by Dr Mark Sywak.

Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Pregnancy. Mental impairment

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation concealment was performed as randomization by sealed envelopes.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Blocked randomization will be used and randomization will be done in the operating theatre after induction of anaesthetics.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
A student T-test, assuming a common standard deviation of 1.5 mmHg and 43mmHg pCO2 in one group and 45 mmHg pCO2 in the other group, using a power of 90% and an alpha level of 0.05, a sample size of 12 patients in each group would be needed.

Data analysis will include statistical testing between groups of blood gas pCO2, pH and endtidal pCO2 after 30 and 60 minutes as well as difference in operative time.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
3/03/2014
Actual
3/03/2014
Date of last participant enrolment
Anticipated
31/03/2015
Actual
31/03/2015
Date of last data collection
Anticipated
Actual
31/03/2015
Sample size
Target
30
Accrual to date
Final
33
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 2517 0
North Shore Private Hospital - St Leonards
Recruitment postcode(s) [1] 8207 0
2065 - Royal North Shore Hospital

Funding & Sponsors
Funding source category [1] 289313 0
Self funded/Unfunded
Name [1] 289313 0
Unfunded
Country [1] 289313 0
Primary sponsor type
Individual
Name
Dr Mark Sywak
Address
Dr Mark Sywak
Sydney Endocrine Surgical Unit
suite 202, 69 Christie Street
St Leonards 2065
NSW
Country
Australia
Secondary sponsor category [1] 287984 0
None
Name [1] 287984 0
Address [1] 287984 0
Country [1] 287984 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 291077 0
North shore Private hospital ethics committee
Ethics committee address [1] 291077 0
Ethics committee country [1] 291077 0
Australia
Date submitted for ethics approval [1] 291077 0
Approval date [1] 291077 0
21/02/2014
Ethics approval number [1] 291077 0
NSPHEC 2013-008

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 48806 0
A/Prof Mark Sywak
Address 48806 0
A/prof Mark Sywak
Sydney Endocrine Surgical Unit
Suite 202, 69 Christie Street
St Leonards 2065
NSW
Country 48806 0
Australia
Phone 48806 0
+61 2 9437 1731
Fax 48806 0
Email 48806 0
[email protected]
Contact person for public queries
Name 48807 0
Mark Sywak
Address 48807 0
A/prof Mark Sywak
Sydney Endocrine Surgical Unit
Suite 202, 69 Christie Street
St Leonards 2065
NSW
Country 48807 0
Australia
Phone 48807 0
+61 2 9437 1731
Fax 48807 0
Email 48807 0
[email protected]
Contact person for scientific queries
Name 48808 0
Mark Sywak
Address 48808 0
A/prof Mark Sywak
Sydney Endocrine Surgical Unit
Suite 202, 69 Christie Street
St Leonards 2065
NSW
Country 48808 0
Australia
Phone 48808 0
+61 2 9437 1731
Fax 48808 0
Email 48808 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.